Leanne M. Rakers

Ms. Rakers' patent practice is concentrated on preparing and prosecuting patent applications in pharmaceutical, life science and biotechnological arts, including small molecule chemistry, therapeutic methods, organometallic chemistry and recombinant DNA technology. She prepares legal opinions, including patent infringement, freedom-to-practice, and due-diligence assessments.

Ms. Rakers also has patent and FDA regulatory experience including Patent drug FDA expertise, Patent Term Extension applications and Orange book assessments.

Ms. Rakers has studied cell cycle inhibitors and suppressors of cytokine signaling at Pennsylvania State University and GlaxoSmithKline Pharmaceuticals. Subsequently, Ms. Rakers focused on recombinant protein expression at Sigma-Aldrich Corporation and is a co-inventor of U.S. Patent No. 6,902,914 (Recombinant DNA Processes Using A dNTP Mixture Containing Modified Nucleotides).

Education

Honors & Distinctions

• Graduated cum laude, Pennsylvania State University
• Intellectual Property Law and Business Formation Clinic, Nidus Center

Professional Affiliations

• AIPLA
• Bar Association of Metropolitan St. Louis

Speaking Engagements

• Ms. Rakers has conducted a variety of lectures on patent prosecution sponsored by the Swedish Patent Office in Stockholm, Sweden, on topics including the legislatively enacted AIA and judicially imposed Supreme Court mandates.